Variable | AKI (n = 67) | Non-AKI (n = 67) | P value | Standardized differences |
---|---|---|---|---|
Gender | Male/Female (48/19) | Male/Female (43/24) | 0.46 | 0.15 |
Age (month) | 2 (1.0–7.0) | 3.0 (1.5–9.6) | 0.25 | 0.24 |
eGFR (ml/min/1.73 m2) | 81.1 (54.3–95.4) | 103.40 (71.0–140.6) | 0.01* | 0.63 |
Weight (kg) | 4.4 (3.5–6.0) | 6.0 (4.5–8.5) |  < .001* | 0.75 |
Premature | 12 (0.18) | 5 (0.07) | 0.07 | 0.34 |
Cyanosis | 36 (0.53) | 17 (0.25) | 0.01* | 0.59 |
RACHS | III/IV/V (43/14/10) | III/IV/V (58/3/6) | 0.01* | 0.53 |
CPB strategy | MHCA /DHCA (38/29) | MHCA /DHCA (34/33) | 0.60 | 0.12 |
PDA | 46 (0.68) | 58 (0.86) | 0.45 | 0.43 |
PAH | None/Mild/Moderate/Severe (7/4/11/45) | None/Mild/ Moderate/Severe (14/5/9/39) | 0.15 | 0.31 |
Preoperative diuretics | 15 (0.22) | 14 (0.21) | 0.85 | 0.02â–³ |
Vasoactive drugs | 11 (0.16) | 10 (0.15) | 0.81 | 0.03â–³ |
Surgery (min) | 181 (162–206) | 160(146–190) |  < .001* | 0.86 |
CPB (min) | 92 (73–110) | 106 (94–126) |  < .001* | 0.85 |
ACCT (min) | 62 (52–73) | 47 (43–61) |  < .001* | 0.90 |
Renal. ischemia (min) | 34 (29–40) | 27 (21–35) |  < .001* | 0.83 |